The first Halozyme Therapeutics trade was made in Q2 2023.
Since then Ray Dalio bought shares one more times and sold shares on three occasions. The investor completely sold their stake between Q3 2024 and Q4 2024.
Avg closing price
Price range
Sold -11.5 Thousand shares
Q4 2024
Avg closing price
$51.14
Price range
$42.57
-
$61.09
Sold 65.3% shares (-21.7 Thousand shares)
Q3 2024
Avg closing price
$57.35
Price range
$51.30
-
$64.42
Increased shares by 370.4% (+26.2 Thousand shares)
Q2 2024